Engagement — Add-on Due Diligence
Code & Co. provides Tech & Product Due Diligence to synava Group, a portfolio company of funds advised by BU, ahead of their partnership with IT-Choice, a mid-sized German company with extensive experience in tumor documentation.
The synava Group, an alliance of leading healthcare IT companies, broadens its scope with the addition of IT-Choice, an established provider of oncology documentation systems. This step creates a strong foundation to jointly develop innovative solutions, leverage synergies, and strategically drive growth.
Scope of Work
Code & Co. conducted a comprehensive due diligence of IT-Choice's oncology software platform. The assessment included an in-depth review of its dual-stack architecture, infrastructure, technology stack, and security measures.
Furthermore, Code & Co. evaluated the company's product roadmap, integration ecosystem, regulatory alignment, and operational scalability. The due diligence also encompassed an evaluation of the engineering organization, software development lifecycle, and regulatory certifications.
About IT-Choice
IT-Choice Software GmbH is a medium-sized company specializing in software solutions for healthcare. The company is an expert in tumor documentation and offers ONKOSTAR, a user-friendly documentation system that supports the collection of patient data, reporting to state cancer registries, the organization and execution of tumor boards, as well as the certification of cancer centers.
With its solutions, IT-Choice Software aims to deliver outstanding results and help clients enhance quality in healthcare and improve therapies. Customer orientation, patient safety, and data protection are always top priorities. https://www.it-choice.de
About synava
synava unites leading healthcare IT companies under one strong umbrella brand: medavis, Digithurst, epiNET, InformMe, MedDream, and POTTHOFF + PARTNER. Together, they shape the digital transformation of healthcare with innovative software solutions that deliver outstanding user-friendliness and make medical processes more efficient.
The portfolio spans from comprehensive end-to-end solutions to specialized applications that integrate seamlessly. With combined expertise, decades of experience, and a consistent customer focus, synava sets new standards for future-proof IT systems. The brand stands for innovation, synergies, and healthcare that evolves with the demands of the future. More information: www.synava.com/de/
About BU
BU is a leading investment firm with offices in Zug, Munich, Milan and London. With €7.0bn in capital raised to date, BU is the largest mid-cap investor headquartered in the DACH region. The funds advised by BU invest in mid-sized companies based in Germany, Switzerland, Italy, and Austria. With the mission to be the partner of choice for entrepreneurs and family-owned businesses, BU seeks to partner with market leaders and “hidden champions” with strong management teams and breakout potential. Since its founding in 2015, the funds advised by BU have invested over €3.5 billion in more than 150 companies with more than 29,000 employees. Thereby, more than 10,000 jobs have been created. BU supports entrepreneurs and families as a strategic partner to develop, internationalize, and digitize their businesses, while helping them generate sustainable value on a responsible basis with the next generation in mind. For more information, please visit www.bu-partners.com or find them on LinkedIn.